Variables | Number of participants (%) | Adjusted at follow-upa | Adjusted at follow-up* | |||||
---|---|---|---|---|---|---|---|---|
Total** | Control | Total** | Intervention | Odds ratio (95% CI) | P value | Odds ratio (95% CI) | P value | |
Complete caseb | ||||||||
 Statin adherence (urine) | 66 | 36 (55) | 54 | 34 (63) | 0.91 (0.31 to 2.67) | 0.860 | 1.37 (0.66 to 2.88) | 0.399 |
 Statin adherence (MMAS) | 95 | 36 (38) | 79 | 37 (47) | 1.82 (0.89 to 3.74) | 0.103 | 1.46 (0.79 to 2.69) | 0.227 |
Intention to treatc | ||||||||
 Statin adherence (urine) | 107 | 62 (57) | 105 | 66 (63) | 0.79 (0.30 to 2.09) | 0.638 | 1.24 (0.62 to 2.47) | 0.541 |
 Statin adherence (MMAS) | 107 | 39(36) | 105 | 48 (46) | 1.81 (0.89 to 3.67) | 0.101 | 1.48 (0.82 to 2.69) | 0.193 |
Per protocold | ||||||||
 Statin adherence (urine) | 66 | 36 (55) | 48 | 31 (61) | 0.88 (0.30 to 2.61) | 0.824 | 1.25 (0.59 to 2.64) | 0.560 |
 Statin adherence (MMAS) | 95 | 36 (38) | 74 | 36 (49) | 1.93 (0.93 to 3.99) | 0.076 | 1.55 (0.83 to (2.90) | 0.164 |
Urine-MMAS datae | 95 | 47 (50) | 80 | 46 (58) | 0.97 (0.48 to 1.99) | 0.945 | 1.37 (0.75 to 2.50) | 0.301 |